Overexpression of transposable elements underlies immune overdrive and poor clinical outcome in cancer patients

The immune system plays a key role in protection against cancer. Increased immune infiltration in tumor tissue is usually associated with improved clinical outcome, but in colorectal cancer, excessive immune infiltration has also been shown to lead to worst prognosis. The factors underlying this immune overdrive phenotype remains unknown. In this study, using colorectal cancer as a model, we develop a transposable element (TE) expression score that stratifies patients into four clusters with distinctive prognosis. Those with the highest TE expression are associated with immune overdrive and have the poorest outcomes. Importantly, this association is independent of microsatellite instability status and tumor mutation burden. To demonstrate that TE reactivation is responsible for the immune overdrive phenotype, we show that cell lines treated with DNA methyltransferase inhibitors also have a high TE expression score and activation of cellular innate immune response pathways. Finally, a pan-cancer survey of TE expression identify a subset of kidney renal clear cell carcinoma with a similar adverse immune overdrive phenotype with poor prognosis. Together, our findings reveal that TE expression underlies the immune overdrive phenotype in cancer and is predicative of immune infiltration and patient prognosis in cancer patients.

[1]  G. Cristofari,et al.  Measuring and interpreting transposable element expression , 2020, Nature Reviews Genetics.

[2]  G. Faulkner,et al.  Nanopore sequencing enables comprehensive transposable element epigenomic profiling , 2020, bioRxiv.

[3]  P. Gendron,et al.  Widespread and tissue-specific expression of endogenous retroelements in human somatic tissues , 2020, Genome Medicine.

[4]  K. Burns Our Conflict with Transposable Elements and Its Implications for Human Disease. , 2020, Annual review of pathology.

[5]  L. Siu,et al.  Molecular profiling for precision cancer therapies , 2020, Genome medicine.

[6]  P. Hegde,et al.  Top 10 Challenges in Cancer Immunotherapy. , 2020, Immunity.

[7]  M. Fakih,et al.  Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome. , 2019, The Journal of clinical investigation.

[8]  R. Guigó,et al.  Atlas of transcriptionally active transposable elements in human adult tissues , 2019, bioRxiv.

[9]  C. A. Fajardo,et al.  Determinants for Neoantigen Identification , 2019, Front. Immunol..

[10]  Diana Romero TMB is linked with prognosis , 2019, Nature Reviews Clinical Oncology.

[11]  Cristian Chaparro,et al.  On the Importance to Acknowledge Transposable Elements in Epigenomic Analyses , 2019, Genes.

[12]  M. Branco,et al.  Regulation of transposable elements by DNA modifications , 2019, Nature Reviews Genetics.

[13]  Peter A. Jones,et al.  Epigenetic therapy in immune-oncology , 2019, Nature Reviews Cancer.

[14]  K. Burns,et al.  SQuIRE reveals locus-specific regulation of interspersed repeat expression , 2019, Nucleic acids research.

[15]  Y. Loh,et al.  Transposable elements are regulated by context-specific patterns of chromatin marks in mouse embryonic stem cells , 2019, Nature Communications.

[16]  R. Bourgon,et al.  Transposable Element Exprssion in Tumors is Associated with Immune Infiltration and Increased Antigenicity , 2018, bioRxiv.

[17]  G. Bourque,et al.  Ten things you should know about transposable elements , 2018, Genome Biology.

[18]  P. Bose,et al.  TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure , 2018, Nature Communications.

[19]  J. Lunceford,et al.  Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy , 2018, Science.

[20]  Sara R. Selitsky,et al.  Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma , 2018, The Journal of clinical investigation.

[21]  Keith A. Crandall,et al.  Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression , 2018, bioRxiv.

[22]  G. Bhanot,et al.  Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. , 2018, JCI insight.

[23]  J. Roszik,et al.  Mining Public Databases for Precision Oncology. , 2018, Trends in cancer.

[24]  F. Marincola,et al.  International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study , 2018, The Lancet.

[25]  Adrian V. Lee,et al.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics , 2018, Cell.

[26]  Steven J. M. Jones,et al.  The Immune Landscape of Cancer , 2018, Immunity.

[27]  Barry Smith,et al.  ImmPort, toward repurposing of open access immunological assay data for translational and clinical research , 2018, Scientific Data.

[28]  Camille Stephan-Otto Attolini,et al.  TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis , 2018, Nature.

[29]  Zhandong Liu,et al.  An ultra-fast and scalable quantification pipeline for transposable elements from next generation sequencing data , 2018, PSB.

[30]  Yingyan Yu Molecular classification and precision therapy of cancer: immune checkpoint inhibitors , 2018, Frontiers of Medicine.

[31]  Nakul M. Shah,et al.  DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats , 2017, Nature Genetics.

[32]  Christopher M. Vockley,et al.  Genome-wide quantification of the effects of DNA methylation on human gene regulation , 2017, bioRxiv.

[33]  Jeong Eon Lee,et al.  Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer , 2017, Nature Communications.

[34]  U. Lehmann,et al.  Transposable Elements in Human Cancer: Causes and Consequences of Deregulation , 2017, International journal of molecular sciences.

[35]  Pengpeng Xia,et al.  RNA sensors of the innate immune system and their detection of pathogens , 2017, IUBMB life.

[36]  P. Kuppen,et al.  Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer , 2016, International journal of molecular sciences.

[37]  P. Laurent-Puig,et al.  Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression , 2016, Genome Biology.

[38]  Amanda E. Jones,et al.  p53 in the game of transposons , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.

[39]  Victor V Lobanenkov,et al.  The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements , 2016, Epigenetics & Chromatin.

[40]  Eilon Barnea,et al.  Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy * , 2016, Molecular & Cellular Proteomics.

[41]  G. Faulkner,et al.  Transposable elements in the mammalian embryo: pioneers surviving through stealth and service , 2016, Genome Biology.

[42]  C. Feschotte,et al.  Regulatory evolution of innate immunity through co-option of endogenous retroviruses , 2016, Science.

[43]  M. Beckmann,et al.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses , 2016, Cell.

[44]  N. Socci,et al.  Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity , 2015, Nature Biotechnology.

[45]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[46]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[47]  Trevor J Pugh,et al.  DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts , 2015, Cell.

[48]  N. Hacohen,et al.  Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.

[49]  H. Baba,et al.  LINE-1 Methylation Level and Patient Prognosis in a Database of 208 Hepatocellular Carcinomas , 2015, Annals of Surgical Oncology.

[50]  J. Boeke,et al.  Sleeping dogs of the genome , 2014, Science.

[51]  Benjamin J. Raphael,et al.  Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.

[52]  N. Neretti,et al.  Transcriptional landscape of repetitive elements in normal and cancer human cells , 2014, BMC Genomics.

[53]  F. Marincola,et al.  Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours , 2013, The Journal of pathology.

[54]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[55]  Michael P. Schroeder,et al.  IntOGen-mutations identifies cancer drivers across tumor types , 2013, Nature Methods.

[56]  M. Schlee Master sensors of pathogenic RNA – RIG-I like receptors , 2013, Immunobiology.

[57]  Seung‐Mo Hong,et al.  K-Adaptive Partitioning for Survival Data, with an Application to Cancer Staging , 2013, 1306.4615.

[58]  Keith L. Ligon,et al.  DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape , 2013, Nature Genetics.

[59]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[60]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[61]  D. Mager,et al.  Transposable elements: an abundant and natural source of regulatory sequences for host genes. , 2012, Annual review of genetics.

[62]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[63]  Lovelace J. Luquette,et al.  Landscape of Somatic Retrotransposition in Human Cancers , 2012, Science.

[64]  R. Santella,et al.  DNA methylation in white blood cells , 2011, Epigenetics.

[65]  R. Labianca,et al.  Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  Lovelace J Luquette,et al.  Estimating enrichment of repetitive elements from high-throughput sequence data , 2010, Genome Biology.

[67]  Ajay Goel,et al.  Microsatellite instability in colorectal cancer. , 2010, Gastroenterology.

[68]  Peter A. Jones,et al.  Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer , 2010, PLoS genetics.

[69]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[70]  Ben S. Wittner,et al.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.

[71]  Nansheng Chen,et al.  Using RepeatMasker to Identify Repetitive Elements in Genomic Sequences , 2009, Current protocols in bioinformatics.

[72]  A. Cassidy,et al.  Hypomethylation of retrotransposable elements correlates with genomic instability in non‐small cell lung cancer , 2009, International journal of cancer.

[73]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[74]  M. Esteller Epigenetics in cancer. , 2008, The New England journal of medicine.

[75]  G. Schumann APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition. , 2007, Biochemical Society transactions.

[76]  R. Martienssen,et al.  Transposable elements and the epigenetic regulation of the genome , 2007, Nature Reviews Genetics.

[77]  W. Gerald,et al.  A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies , 2006, PLoS medicine.

[78]  R. Houlston,et al.  Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  J. Issa CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.

[80]  A. Bennaceur-Griscelli,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2002 .

[81]  Daniel J Sargent,et al.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.

[82]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[83]  S. Bull,et al.  Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. , 2000, The New England journal of medicine.

[84]  V. Corces,et al.  Transposable element-host interactions: regulation of insertion and excision. , 1997, Annual review of genetics.